DE3484779D1 - Pharmazeutische mittel. - Google Patents

Pharmazeutische mittel.

Info

Publication number
DE3484779D1
DE3484779D1 DE8484301238T DE3484779T DE3484779D1 DE 3484779 D1 DE3484779 D1 DE 3484779D1 DE 8484301238 T DE8484301238 T DE 8484301238T DE 3484779 T DE3484779 T DE 3484779T DE 3484779 D1 DE3484779 D1 DE 3484779D1
Authority
DE
Germany
Prior art keywords
sorbitol
polyethylene glycol
capsule shell
pharmaceutical agents
sorbitans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484301238T
Other languages
English (en)
Inventor
Werner Brox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10538838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3484779(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Application granted granted Critical
Publication of DE3484779D1 publication Critical patent/DE3484779D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8484301238T 1983-03-02 1984-02-27 Pharmazeutische mittel. Expired - Lifetime DE3484779D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838305693A GB8305693D0 (en) 1983-03-02 1983-03-02 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3484779D1 true DE3484779D1 (de) 1991-08-14

Family

ID=10538838

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484301238T Expired - Lifetime DE3484779D1 (de) 1983-03-02 1984-02-27 Pharmazeutische mittel.

Country Status (14)

Country Link
US (1) US4780316A (de)
EP (1) EP0121321B1 (de)
JP (1) JPH06695B2 (de)
KR (1) KR890000117B1 (de)
AT (1) ATE65023T1 (de)
AU (1) AU566832B1 (de)
CA (1) CA1211049A (de)
DE (1) DE3484779D1 (de)
DK (1) DK162875C (de)
ES (1) ES530270A0 (de)
FI (1) FI79244C (de)
GB (1) GB8305693D0 (de)
NO (1) NO840793L (de)
WO (1) WO1984003416A1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211954A (en) * 1986-09-23 1993-05-18 Sandoz Ltd. Low dose temazepam
CH673947A5 (de) * 1986-09-23 1990-04-30 Sandoz Ag
US5030632A (en) * 1986-09-23 1991-07-09 Sandoz Pharm. Corp. Low dose temazepam
US5629310A (en) * 1986-09-23 1997-05-13 Sterling; William R. Low dose temazepam
GB8701332D0 (en) * 1987-01-21 1987-02-25 Lilly Industries Ltd Capsule filling
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5200191A (en) * 1991-09-11 1993-04-06 Banner Gelatin Products Corp. Softgel manufacturing process
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
SI1033128T2 (sl) * 1993-09-28 2012-02-29 Scherer Gmbh R P Izdelava mehke Ĺľelatinaste kapsule
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
FR2728464B1 (fr) 1994-12-22 1997-04-30 Innothera Lab Sa Forme galenique unitaire, son procede d'obtention et ses utilisations
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US6077513A (en) * 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
AU754712B2 (en) * 1999-02-26 2002-11-21 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US20030124225A1 (en) * 1999-11-01 2003-07-03 Paul West Encapsulated alcoholic beverage
US20030034458A1 (en) * 2001-03-30 2003-02-20 Fuji Photo Film Co., Ltd. Radiation image storage panel
US6752953B2 (en) * 2001-12-03 2004-06-22 Yung Shin Pharmaceutical Co., Ltd. Method for manufacturing hard non-gelatin pharmaceutical capsules
CN1655770A (zh) 2002-04-25 2005-08-17 旗帜药物胶囊公司 可咀嚼的软胶囊
US20050058703A1 (en) * 2003-08-01 2005-03-17 Chang Robert C. Gelatin capsules
US20050230871A1 (en) * 2004-04-20 2005-10-20 Bess William S Fast-dissolving films
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
US20060153824A1 (en) * 2005-01-13 2006-07-13 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US7485609B2 (en) * 2005-09-29 2009-02-03 Kimberly-Clark Worldwide, Inc. Encapsulated liquid cleanser
US20070134493A1 (en) * 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
KR20180027615A (ko) 2006-01-24 2018-03-14 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
WO2007086536A2 (en) 2006-01-24 2007-08-02 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
US20090110724A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of pain
US20100285121A1 (en) * 2008-01-10 2010-11-11 Takeda Pharmaceutical Company Limited Capsule Formulation
US20090214641A1 (en) * 2008-02-26 2009-08-27 Joar Opheim Sweetened Capsules for Administration
PL2299987T3 (pl) 2008-06-06 2018-08-31 Boehringer Ingelheim International Gmbh Farmaceutyczna postać dawkowania w formie kapsułki zawierająca formulację zwiesiny pochodnej indolinonu
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
US8621764B2 (en) 2011-03-16 2014-01-07 John PUCKETT Gelatin capsule formulation and drying system
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
CN102225055B (zh) * 2011-06-14 2012-05-23 贵州地道药业有限公司 一种软胶囊囊壳配方
AU2012324013A1 (en) * 2011-11-03 2013-05-23 Gtx, Inc. Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof
KR101466617B1 (ko) * 2011-11-17 2014-11-28 한미약품 주식회사 오메가-3 지방산 및 HMG-CoA 환원효소 억제제를 포함하는 안정성이 증가된 경구용 복합 제제
WO2013165789A1 (en) * 2012-04-30 2013-11-07 Dow Agrosciences Llc Pesticide composition delivery vehicles
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
US20150335586A1 (en) 2014-05-20 2015-11-26 R.P. Scherer Technologies, Llc Capsule dispensing container
WO2016044805A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
EP3053598A1 (de) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol-Weichkapseln
JP6019204B1 (ja) * 2015-11-30 2016-11-02 三生医薬株式会社 ソフトカプセル剤
ITUB20156821A1 (it) * 2015-12-09 2017-06-09 Altergon Sa CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE
NL2017219B1 (en) 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
MX2020012233A (es) * 2018-05-16 2021-01-29 Bayer Healthcare Llc Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe.
TW202106280A (zh) * 2019-08-08 2021-02-16 英諾美生物科技股份有限公司 保存潤滑劑用之膠囊
US11583552B2 (en) 2021-02-17 2023-02-21 Manoj Maniar Pharmaceutical formulation of arsenic trioxide
EP4176724A1 (de) 2021-11-09 2023-05-10 Universität Hohenheim Verwendung eines oleogels als eine schicht oder beschichtung

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2172357A (en) * 1938-01-29 1939-09-12 Atlas Powder Co Composition
GB715879A (en) * 1952-06-23 1954-09-22 Scherer Corp R P Improvements in or relating to gelatin capsule and method of making the same
US2870060A (en) * 1956-02-07 1959-01-20 Mead Johnson & Co Stable encapsulated solution of a salt of a dialkyl sulfosuccinate
US2870062A (en) * 1956-04-27 1959-01-20 Scherer Corp R P Gelatin composition for capsules
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
US2847346A (en) * 1956-11-20 1958-08-12 Lloyd Brothers Inc Laxative compositions contaqining dioctyl sodium sulfosuccinate and 1, 8-dihydroxyanthraquinone
DE1617629A1 (de) * 1966-11-09 1971-03-25 Merck Patent Gmbh Verfahren zur Stabilisierung von Bromelin in Arzneimittelzubereitungen
US3520971A (en) * 1966-12-05 1970-07-21 Scherer Corp R P Bath capsule
FR1599474A (de) * 1968-12-27 1970-07-15
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3779942A (en) * 1970-12-04 1973-12-18 Minnesota Mining & Mfg Capsules and process for forming capsules
SU432703A3 (de) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
BE825842A (fr) * 1974-02-22 1975-08-21 Compositions pharmaceutiques comprenant de la digoxine
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
JPS5931711A (ja) * 1982-07-19 1984-02-20 シンテツクス（ユ−・エス・エイ）インコ−ポレ−テツド 酸単離ゼラチンにより被包したｐｇｅ型組成物

Also Published As

Publication number Publication date
EP0121321B1 (de) 1991-07-10
ES8503508A1 (es) 1985-03-16
DK146784D0 (da) 1984-02-29
FI79244B (fi) 1989-08-31
EP0121321A2 (de) 1984-10-10
DK162875C (da) 1992-05-18
DK162875B (da) 1991-12-23
EP0121321A3 (en) 1986-01-29
ES530270A0 (es) 1985-03-16
KR850002954A (ko) 1985-05-28
KR890000117B1 (ko) 1989-03-08
DK146784A (da) 1984-09-03
AU566832B1 (en) 1987-10-29
NO840793L (no) 1984-09-03
FI79244C (fi) 1989-12-11
JPS60500867A (ja) 1985-06-06
US4780316A (en) 1988-10-25
ATE65023T1 (de) 1991-07-15
FI840832A0 (fi) 1984-03-01
CA1211049A (en) 1986-09-09
JPH06695B2 (ja) 1994-01-05
FI840832A (fi) 1984-09-03
WO1984003416A1 (en) 1984-09-13
GB8305693D0 (en) 1983-04-07

Similar Documents

Publication Publication Date Title
DE3484779D1 (de) Pharmazeutische mittel.
ES2138661T3 (es) Formulaciones de dosis elevadas.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO874960L (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
ES2090368T3 (es) Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral.
IT8921132A0 (it) Inalatore per medicamenti in capsule.
IT1182253B (it) Dispositivo ad azione osmotica per la somministrazione di un agente benefico all ambiente circostante particolarmente per la somministrazione di farmaci in ambito gastrointe stinale
IT1148238B (it) Dispositivo per la somministrazione di medicamenti in polvere
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2134953T3 (es) Capsulas de gelatina que contienen una solucion de acetaminofeno altamente concentrada.
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
IT1240768B (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ES2176805T3 (es) Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
FR2556216B1 (fr) Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques
DE68903597D1 (de) Weichkapselzubereitung von natriumpicosulfat.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ES265931Y (es) "dispositivo para la presentacion, en bateria, de dosis de microcomprimidos medicamentosos".
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
IT8348524A0 (it) Associazione antiobiotica di fosfomicina e cefatrizina per uso umano nelle forme farmaceutiche capsule opercolate,compresse e bustine di granulato
KR890700580A (ko) 진경 작용을 갖는 제약 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition